Cannabinoid receptor ligands
US7718702B2 · kind B2 · utility
5Cited by
18References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2005 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Feb 28, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are disclosed compounds of the formulaa prodrug thereof, or a pharmaceutically acceptable salt, solvate or stereoisomer of the compound or of said prodrug; which exhibit anti-inflammatory and immunodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds and methods of using the compounds for the treatment of various diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.